冠状动脉生物可吸收支架临床应用最新进展  

Clinical Application of Coronary Bioabsorbable Scaffolds

作　　者：刘明阳 赵晨[1] 郝伟 贾海波[1] 于波[1] LIU Mingyang;ZHAO Chen;HAO Wei;JIA Haibo;YU Bo(Department of Cardiology,The Second Affiliated Hospital of Harbin Medical University,The Key Laboratory of Myocardial Ischemia,Chinese Ministry of Education,Harbin 150081,Heilongjiang,China)

机构地区：[1]哈尔滨医科大学附属第二医院心血管内科教育部心肌缺血重点实验室,黑龙江哈尔滨150081

出　　处：《心血管病学进展》2023年第7期649-653,663,共6页Advances in Cardiovascular Diseases

基　　金：黑龙江省自然科学基金研究团队项目(TD2020H001)。

摘　　要：生物可吸收支架作为一种创新型支架产品,由于其植入后可完全吸收,进而可恢复血管正常生理功能,被誉为冠状动脉介入治疗领域的“第四次革命”。在上市之初便被寄予厚望,然而先前的临床效用结果并未达到其预期。近年来,大量的临床数据为新一代生物可吸收支架的研发和应用提供了许多宝贵的经验。现总结既往研究经验,并就生物可吸收支架的最新研发进展及临床应用进行综述。Bioresorbable scaffold,as an innovative stent product,has been hailed as the“fourth revolution”in the field of coronary artery intervention therapy due to its ability to be entirely absorbed and restore normal vascular function after implantation.At the beginning of its listing,high expectations were placed,but previous clinical efficacy results did not meet its expectations.In recent years,a wealth of clinical data has provided valuable experience for the development and application of next-generation bioresorbable scaffolds.This article aims to summarize previous research findings and review the latest development and clinical application of bioresorbable scaffolds.

关 键 词：生物可吸收支架 经皮冠状动脉介入治疗 支架内血栓 血管内影像学 

分 类 号：R318.08[医药卫生—生物医学工程]